Prospects of stem cell therapy in osteoarthritis.

Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/stem cells, however, appear to be the leading candidates because of their ability to be sourced from many or all joint tissues. They may also modulate the immune response of individuals, in a manner influenced by local factors. This biological behavior of stem cells renders the application of regulatory standardizations challenging in comparison to pharmaceutical therapies. However, this would not be an issue if endogenous stem cells were activated to effect repair of an arthritic joint.

[1]  P G Pelicci,et al.  Genomic instability in induced stem cells , 2011, Cell Death and Differentiation.

[2]  H. Anderson,et al.  Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. , 2011, Histology and histopathology.

[3]  Xiao-bing Fu,et al.  MSCs: Biological characteristics, clinical applications and their outstanding concerns , 2011, Ageing Research Reviews.

[4]  A. Nicolaou,et al.  The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. , 2010, International immunopharmacology.

[5]  R. Mu,et al.  Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis , 2010, Arthritis Research & Therapy.

[6]  R. Yañez,et al.  Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. , 2010, Experimental cell research.

[7]  Bjarni V. Halldórsson,et al.  Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22 , 2010, Annals of the rheumatic diseases.

[8]  S. Kimber,et al.  Directed differentiation of human embryonic stem cells toward chondrocytes , 2010, Nature Biotechnology.

[9]  H. Sun.  Mechanical loading, cartilage degradation, and arthritis , 2010, Annals of the New York Academy of Sciences.

[10]  S. Simonsson,et al.  Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination , 2010, Aging.

[11]  Ilyas M. Khan,et al.  Identification and Clonal Characterisation of a Progenitor Cell Sub-Population in Normal Human Articular Cartilage , 2010, PloS one.

[12]  S. Goldring,et al.  Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other? , 2010, Arthritis Research & Therapy.

[13]  O. Okamoto,et al.  Células-tronco derivadas de tecido adiposo humano: desafios atuais e perspectivas clínicas , 2010 .

[14]  M. Blasco,et al.  The role of telomeres and telomerase in stem cell aging , 2010, FEBS letters.

[15]  W. Holzgreve,et al.  Umbilical cord blood stem cells: what to expect , 2010, Annals of the New York Academy of Sciences.

[16]  Donald G Phinney,et al.  Defining the risks of mesenchymal stromal cell therapy. , 2010, Cytotherapy.

[17]  P. Bianco,et al.  "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. , 2010, Human gene therapy.

[18]  Hai Yao,et al.  Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study , 2010, The Lancet.

[19]  R. Bjerkvig,et al.  Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. , 2010, Cancer research.

[20]  Shinya Yamanaka,et al.  Promotion of direct reprogramming by transformation-deficient Myc , 2010, Proceedings of the National Academy of Sciences.

[21]  S. Hamdy,et al.  Case Control Series of Intrathecal Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury , 2010, Neurorehabilitation and neural repair.

[22]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[23]  Ronald G. Tompkins,et al.  Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing , 2010, Cell transplantation.

[24]  D. Herndon,et al.  Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. , 2010, Stem cells and development.

[25]  Ivan Martin,et al.  Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering , 2010, Proceedings of the National Academy of Sciences.

[26]  S. Koelling,et al.  Sex differences of chondrogenic progenitor cells in late stages of osteoarthritis. , 2010, Arthritis and rheumatism.

[27]  W. Marasco,et al.  Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. , 2010, Current stem cell research & therapy.

[28]  Hélène Rouard,et al.  Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. , 2010, Blood.

[29]  M. Baker.  Testing time for stem cells , 2010, Nature.

[30]  Johan Bellemans,et al.  Treatment of Symptomatic Cartilage Defects of the Knee , 2009, The American journal of sports medicine.

[31]  J. Roncalli,et al.  Mesenchymal Stem Cells Promote Matrix Metalloproteinase Secretion by Cardiac Fibroblasts and Reduce Cardiac Ventricular Fibrosis After Myocardial Infarction , 2009, Stem cells.

[32]  J. Kuiper,et al.  Midterm to Long-Term Longitudinal Outcome of Autologous Chondrocyte Implantation in the Knee Joint , 2009, The American journal of sports medicine.

[33]  J. Richardson,et al.  Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. , 2009, Bone.

[34]  E. Melamed,et al.  Introducing Transcription Factors to Multipotent Mesenchymal Stem Cells: Making Transdifferentiation Possible , 2009, Stem cells.

[35]  F. Dell’Accio,et al.  Distinct mesenchymal progenitor cell subsets in the adult human synovium. , 2009, Rheumatology.

[36]  C. Scaletta,et al.  Isolation and in vitro chondrogenic potential of human foetal spine cells , 2009, Journal of cellular and molecular medicine.

[37]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[38]  S. Narumiya,et al.  Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion , 2009, Nature Medicine.

[39]  F. Dell’Accio,et al.  A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury , 2009, Osteoarthritis and cartilage.

[40]  N. Anagnou,et al.  Novel sources of fetal stem cells: where do they fit on the developmental continuum? , 2009, Regenerative medicine.

[41]  Jochen Ringe,et al.  Specific Lineage‐Priming of Bone Marrow Mesenchymal Stem Cells Provides the Molecular Framework for Their Plasticity , 2009, Stem cells.

[42]  M. Baker.  Stem cells: Fast and furious , 2009, Nature.

[43]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[44]  S. Koelling,et al.  Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. , 2009, Cell stem cell.

[45]  S. Gilbert,et al.  Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. , 2009, Osteoarthritis and cartilage.

[46]  C. Kaps,et al.  Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results , 2009, Arthritis research & therapy.

[47]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[48]  J. Deprest,et al.  Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine , 2009, BJOG : an international journal of obstetrics and gynaecology.

[49]  Sara Mantero,et al.  Clinical transplantation of a tissue-engineered airway , 2008, The Lancet.

[50]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[51]  E. Geissler,et al.  Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. , 2008, Transplant immunology.

[52]  R. Tuan,et al.  Mesenchymal stem cells in arthritic diseases , 2008, Arthritis research & therapy.

[53]  N. Nardi,et al.  In Search of the In Vivo Identity of Mesenchymal Stem Cells , 2008, Stem cells.

[54]  P. Genever,et al.  Transcriptional Control of Mesenchymal Stem Cell Differentiation , 2008, Transfusion Medicine and Hemotherapy.

[55]  Daniel J. Hoeppner,et al.  Global transcription in pluripotent embryonic stem cells. , 2008, Cell stem cell.

[56]  B. Giusti,et al.  Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model , 2008, Archives of Dermatological Research.

[57]  F. Luyten,et al.  Characterized Chondrocyte Implantation Results in Better Structural Repair When Treating Symptomatic Cartilage Defects of the Knee in a Randomized Controlled Trial versus Microfracture , 2008, The American journal of sports medicine.

[58]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[59]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[60]  P. Emery,et al.  A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. , 2007, Rheumatology.

[61]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[62]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[63]  N. Ashammakhi,et al.  Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation. , 2007, The Journal of bone and joint surgery. British volume.

[64]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[65]  Kris Dierickx,et al.  A critical assessment of the directive on tissue engineering of the European union. , 2007, Tissue engineering.

[66]  Jiake Xu,et al.  Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment. , 2007, Tissue engineering.

[67]  W. Hutton,et al.  Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. , 2007, Biomolecular engineering.

[68]  N. Wulffraat,et al.  Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 , 2007, Arthritis research & therapy.

[69]  Brendan H. Lee,et al.  Dominance of SOX9 function over RUNX2 during skeletogenesis , 2006, Proceedings of the National Academy of Sciences.

[70]  S. Pringle.  The stem cell niche: a new target in medicine , 2006 .

[71]  Thomas Aigner,et al.  Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. , 2006, Arthritis and rheumatism.

[72]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[73]  Tom Misteli,et al.  Chromatin in pluripotent embryonic stem cells and differentiation , 2006, Nature Reviews Molecular Cell Biology.

[74]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[75]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[76]  J. Zeitlinger,et al.  Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.

[77]  N. Pfeffer,et al.  Regulating the collection and use of fetal stem cells , 2006, British medical journal.

[78]  Francesco Dell'Accio,et al.  Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. , 2006, Arthritis and rheumatism.

[79]  F. Cicuttini,et al.  Natural history of knee cartilage defects and factors affecting change. , 2006, Archives of internal medicine.

[80]  Samuli Ripatti,et al.  Determinants of the Progression in Lumbar Degeneration: A 5-Year Follow-up Study of Adult Male Monozygotic Twins , 2006, Spine.

[81]  Y. Sakaguchi,et al.  Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. , 2005, Arthritis and rheumatism.

[82]  P. Robson,et al.  Transcriptional Regulation of Nanog by OCT4 and SOX2* , 2005, Journal of Biological Chemistry.

[83]  J. Cigudosa,et al.  Spontaneous human adult stem cell transformation. , 2005, Cancer research.

[84]  Shridar Ganesan,et al.  Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. , 2005, Genes & development.

[85]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[86]  M. Mattson,et al.  Cellular lifespan and senescence signaling in embryonic stem cells , 2004, Aging cell.

[87]  N. Fisk,et al.  Fetal stem cells. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[88]  J. McConnell,et al.  Lineage allocation and cell polarity during mouse embryogenesis. , 2004, Seminars in cell & developmental biology.

[89]  H. Eufinger,et al.  Growth and transplantation of a custom vascularised bone graft in a man , 2004, The Lancet.

[90]  R. Brenner,et al.  Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers , 2004, Arthritis research & therapy.

[91]  Ilyas M. Khan,et al.  The surface of articular cartilage contains a progenitor cell population , 2004, Journal of Cell Science.

[92]  S. Cannon,et al.  The use of chondrogide membrane in autologous chondrocyte implantation. , 2004, The Knee.

[93]  D. Skalnik,et al.  Histone deacetylase activity is required for embryonic stem cell differentiation , 2004, Genesis.

[94]  Christian Clausen,et al.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. , 2003, Bone.

[95]  P. Emery,et al.  Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. , 2004, Arthritis and rheumatism.

[96]  P. Sharp,et al.  Embryonic stem cell-specific MicroRNAs. , 2003, Developmental cell.

[97]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[98]  S. Gronthos,et al.  Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone Marrow and Dental Pulp , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[99]  K. Shelbourne,et al.  Outcome of Untreated Traumatic Articular Cartilage Defects of the Knee: A Natural History Study , 2003, The Journal of bone and joint surgery. American volume.

[100]  J. Vermeesch,et al.  Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane , 2003, The Journal of cell biology.

[101]  Paul Emery,et al.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. , 2002, Arthritis and rheumatism.

[102]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[103]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[104]  M. Saito,et al.  Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. , 2002, Osteoarthritis and cartilage.

[105]  Kenneth Dixon,et al.  Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. , 2002, Arthritis and rheumatism.

[106]  A. Hollander,et al.  Matrix turnover in human cartilage repair tissue in autologous chondrocyte implantation. , 2001, Arthritis and rheumatism.

[107]  F. Luyten,et al.  Multipotent mesenchymal stem cells from adult human synovial membrane. , 2001, Arthritis and rheumatism.

[108]  F. Luyten,et al.  Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. , 2001, Arthritis and rheumatism.

[109]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[110]  V. Lefebvre,et al.  Transcriptional mechanisms of chondrocyte differentiation. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[111]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[112]  T. Spector,et al.  Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. , 1999, Arthritis and rheumatism.

[113]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[114]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[115]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[116]  K. Messner,et al.  The long-term prognosis for severe damage to weight-bearing cartilage in the knee: a 14-year clinical and radiographic follow-up in 28 young athletes. , 1996, Acta orthopaedica Scandinavica.

[117]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[118]  S. Ratnam,et al.  Isolation and culture of inner cell mass cells from human blastocysts. , 1994, Human reproduction.

[119]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[120]  M J Glimcher,et al.  Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. , 1993, The Journal of bone and joint surgery. American volume.

[121]  R. Leach.  The learning curve , 1992 .

[122]  A. Caplan.  Mesenchymal Stem Cells , 1991, Cartilage.

[123]  S. Bruder,et al.  In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. , 1991, Experimental cell research.

[124]  P. Simmons,et al.  Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1 , 1991 .

[125]  J. Kurtzberg,et al.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.

[126]  Malcolm L. Johnson.  Editorial: Observations on the Enterprise of Ageing , 1982, Ageing & Society.

[127]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[128]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[129]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[130]  F. Luyten,et al.  A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. , 2008, Arthritis and rheumatism.

[131]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[132]  F. Dell’Accio,et al.  Reparative medicine: from tissue engineering to joint surface regeneration. , 2006, Regenerative medicine.

[133]  F. Marini,et al.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.

[134]  Francesco Dell'Accio,et al.  Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. , 2004, Arthritis and rheumatism.

[135]  A. Hollander,et al.  Quantitative analysis of repair tissue biopsies following chondrocyte implantation. , 2003, Novartis Foundation symposium.

[136]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.

[137]  F. Luyten,et al.  Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. , 2001, Arthritis and rheumatism.